Dopamine transporter (DAT) imaging in Parkinson's disease and related disorders

T Brücke, C Brücke - Journal of Neural Transmission, 2022 - Springer
This review gives an insight into the beginnings of dopamine transporter (DAT) imaging in
the early 1990s, focussing on single photon emission tomography (SPECT). The …

In vivo receptor visualization and evaluation of receptor occupancy with positron emission tomography

Y Takamura, H Kakuta - Journal of medicinal chemistry, 2021 - ACS Publications
Positron emission tomography (PET) is useful for noninvasive in vivo visualization of
disease-related receptors, for evaluation of receptor occupancy to determine an appropriate …

Prediction of human CNS pharmacokinetics using a physiologically-based pharmacokinetic modeling approach

Y Yamamoto, PA Välitalo, YC Wong… - European Journal of …, 2018 - Elsevier
Abstract Knowledge of drug concentration-time profiles at the central nervous system (CNS)
target-site is critically important for rational development of CNS targeted drugs. Our aim was …

Preclinical prediction of human brain target site concentrations: considerations in extrapolating to the clinical setting

J Westerhout, M Danhof, ECM De Lange - Journal of pharmaceutical …, 2011 - Elsevier
The development of drugs for central nervous system (CNS) disorders has encountered high
failure rates. In part, this has been due to the sole focus on blood-brain barrier permeability …

Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders

NPLG Verhoeff - Psychopharmacology, 1999 - Springer
This article will review the capabilities and accomplishments of radiotracer imaging with
single photon emission computed tomography (SPECT) and positron emission tomography …

Dopamine-and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia

S Kasper, J Tauscher, B Küfferle, C Barnas… - European Archives of …, 1999 - Springer
Considerable progress has been achieved over the past 15 years in uncovering the
biological basis of major psychiatric disorders. Since psychopharmacological treatment is …

D2 receptor occupancy during high-and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study

C la Fougère, E Meisenzahl, G Schmitt… - Journal of Nuclear …, 2005 - Soc Nuclear Med
Amisulpride appears to be an effective agent for treating positive or negative symptoms of
schizophrenia, depending on dose. The aim of this study was to assess striatal dopamine …

Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia

J Lavalaye, DH Linszen, J Booij, L Reneman… - Psychiatry Research …, 1999 - Elsevier
A crucial characteristic of antipsychotic medication is the occupancy of the dopamine (DA)
D2 receptor. We assessed striatal DA D2 receptor occupancy by olanzapine and risperidone …

Dual SPECT of dopamine system using [99mTc] TRODAT-1 and [123I] IBZM in normal and 6-OHDA-lesioned formosan rock monkeys

KH Ma, WS Huang, CH Chen, SZ Lin, SP Wey… - Nuclear Medicine and …, 2002 - Elsevier
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by a
severe loss of the dopaminergic neurons in the substantia nigra pars compacta. In this study …

Neurochemical dysfunction in treated and nontreated schizophrenia – a retrospective analysis of in vivo imaging studies

S Nikolaus, H Hautzel, HW Müller - Reviews in the Neurosciences, 2014 - degruyter.com
To evaluate the contribution of individual synaptic constituents, all available in vivo imaging
studies on schizophrenic patients were subjected to a retrospective analysis. For the pool of …